Skip to main content
Erschienen in: Wiener Medizinische Wochenschrift 15-16/2020

22.06.2020 | themenschwerpunkt

Die Schilddrüse im Alter

Physiologie und Pathologie

verfasst von: Christina Tugendsam, Amir Kurtaran

Erschienen in: Wiener Medizinische Wochenschrift | Ausgabe 15-16/2020

Einloggen, um Zugang zu erhalten

Zusammenfassung

Gesunde ältere Menschen weisen Änderungen im Schilddrüsenhormonmetabolismus auf, die möglicherweise sogar aktiv zur Langlebigkeit beitragen können. Dies gilt es, auch bei der Behandlung von – prinzipiell ebenso wie bei Jüngeren auftretenden – Schilddrüsenerkrankungen zu berücksichtigen. Besonderheiten ergeben sich auch durch Komorbiditäten, insbesondere im kardiovaskulären Bereich, sodass etwa hyperthyreote Stoffwechsellagen schlechter toleriert werden als bei Herzgesunden. Benigne Knotenstrumen nehmen im Alter an Häufigkeit zu und sollen bei mechanischer Indikation operiert werden. Das Therapiekonzept bei malignen Erkrankungen muss in die Gesamtsituation des Patienten eingebettet werden, unterscheidet sich allerdings prinzipiell nicht von dem jüngerer Patienten. Von einer adäquaten, risikoadaptierten Therapie von Schilddrüsenerkrankungen profitieren auch betagte und hochbetagte Menschen, sodass eine entsprechende Diagnostik und Abklärung in jedem Lebensalter sinnvoll sind.
Literatur
3.
Zurück zum Zitat Hawkes K, Coxwoth JE. Grandmothers and the evolution of human longevity: a review of findings and future directions. Evol Anthropol. 2013;22(6):294–302. Hawkes K, Coxwoth JE. Grandmothers and the evolution of human longevity: a review of findings and future directions. Evol Anthropol. 2013;22(6):294–302.
4.
Zurück zum Zitat Morreale de Escobar G, Obregon MJ, Escobar del Rey F. Role of thyroid hormone during early brain development. Eur J Endocrinol. 2004;151:U25–U37. Morreale de Escobar G, Obregon MJ, Escobar del Rey F. Role of thyroid hormone during early brain development. Eur J Endocrinol. 2004;151:U25–U37.
5.
Zurück zum Zitat Mariotti S, Franceschi C, Cossarizza A, et al. The aging thyroid. Endocr Rev. 1995;16(6):686–715. Mariotti S, Franceschi C, Cossarizza A, et al. The aging thyroid. Endocr Rev. 1995;16(6):686–715.
6.
Zurück zum Zitat Veldhuis JD. Changes in pituitary function with aging and implications for patient care. Nat Rev Endocrinol. 2013;9(4):205–15.PubMed Veldhuis JD. Changes in pituitary function with aging and implications for patient care. Nat Rev Endocrinol. 2013;9(4):205–15.PubMed
7.
Zurück zum Zitat Bowers J, Terrein J, Clerget-Froidevaux MS, et al. Thyroid hormone signaling and homeostasis during aging. Endocr Rev. 2013;34(4):556–89. Bowers J, Terrein J, Clerget-Froidevaux MS, et al. Thyroid hormone signaling and homeostasis during aging. Endocr Rev. 2013;34(4):556–89.
8.
Zurück zum Zitat Hollowell JG, Staehling NW, Flanders WD, et al. Serum TSH, T(4), and thyroid antibodies in the United States population (1988 to 1994): National Health and Nutrition Examination Survey (NHANES III). J Clin Endocrinol Metab. 2002;87(2):489–99.PubMed Hollowell JG, Staehling NW, Flanders WD, et al. Serum TSH, T(4), and thyroid antibodies in the United States population (1988 to 1994): National Health and Nutrition Examination Survey (NHANES III). J Clin Endocrinol Metab. 2002;87(2):489–99.PubMed
9.
Zurück zum Zitat Ravaglia G, Forti P, Maioli F. Blood micronutrient and thyroid hormone concentrations in the oldest-old. J Clin Endocrinol Metab. 2000;85:2260–5. Ravaglia G, Forti P, Maioli F. Blood micronutrient and thyroid hormone concentrations in the oldest-old. J Clin Endocrinol Metab. 2000;85:2260–5.
10.
Zurück zum Zitat Atzmon G, Barzilai N, Hollowell JG, et al. Extreme longevity is associated with increased serum thyrotropin. J Clin Endocrinol Metab. 2009;94(4):1251–4.PubMed Atzmon G, Barzilai N, Hollowell JG, et al. Extreme longevity is associated with increased serum thyrotropin. J Clin Endocrinol Metab. 2009;94(4):1251–4.PubMed
11.
Zurück zum Zitat Atzmon G, Barzilai N, Surks MI, Gabriely I. Genetic predisposition to elevated serum thyrotropin is associated with exceptional longevity. J Clin Endocrinol Metab. 2009;94(12):4768–75.PubMed Atzmon G, Barzilai N, Surks MI, Gabriely I. Genetic predisposition to elevated serum thyrotropin is associated with exceptional longevity. J Clin Endocrinol Metab. 2009;94(12):4768–75.PubMed
12.
Zurück zum Zitat Rozing MP, Houwing-Duistermaat JJ, Slagboom PE, Beekman M, Frölich M, de Craen AJ, et al. Familial longevity is associated with decreased thyroid function. J Clin Endocrinol Metab. 2010;95:4979–84. Rozing MP, Houwing-Duistermaat JJ, Slagboom PE, Beekman M, Frölich M, de Craen AJ, et al. Familial longevity is associated with decreased thyroid function. J Clin Endocrinol Metab. 2010;95:4979–84.
13.
Zurück zum Zitat Jansen SW, Roelfsema F, van der Spoel E. Familial longevity is associated with higher TSH secretion and strong TSH-fT3 relationship. J Clin Endocrinol Metab. 2015;100(10):3806–13. Jansen SW, Roelfsema F, van der Spoel E. Familial longevity is associated with higher TSH secretion and strong TSH-fT3 relationship. J Clin Endocrinol Metab. 2015;100(10):3806–13.
14.
Zurück zum Zitat Ogliari G, Smit RA, van der Spoel E, et al. Thyroid status and mortality risk in older adults with normal thyrotropin: sex differences in the Milan geriatrics 75+ cohort study. J Gerontol A Biol Sci Med Sci. 2017;72(4):554–9. Ogliari G, Smit RA, van der Spoel E, et al. Thyroid status and mortality risk in older adults with normal thyrotropin: sex differences in the Milan geriatrics 75+ cohort study. J Gerontol A Biol Sci Med Sci. 2017;72(4):554–9.
15.
Zurück zum Zitat Bremner AP, Feddema P, Leedmann PJ, et al. Age-related changes in thyroid function: a longitudinal study of a community-based cohort. J Clin Endocrinol Metab. 2012;97(5):1554–62. Bremner AP, Feddema P, Leedmann PJ, et al. Age-related changes in thyroid function: a longitudinal study of a community-based cohort. J Clin Endocrinol Metab. 2012;97(5):1554–62.
16.
Zurück zum Zitat Waring AC, Arnold AM, Newman AB, et al. Longitudinal changes in thyroid function in the oldest old and survival: the cardiovascular health study all-stars study. J Clin Endocrinol Metab. 2012;97(11):3944–50.PubMed Waring AC, Arnold AM, Newman AB, et al. Longitudinal changes in thyroid function in the oldest old and survival: the cardiovascular health study all-stars study. J Clin Endocrinol Metab. 2012;97(11):3944–50.PubMed
17.
Zurück zum Zitat van de Ven AC, Netea-Maier RT, Smit JW, et al. Thyrotropin versus age relation as and indicator of historical iodine intake. Thyroid. 2015;25:629–34. van de Ven AC, Netea-Maier RT, Smit JW, et al. Thyrotropin versus age relation as and indicator of historical iodine intake. Thyroid. 2015;25:629–34.
18.
Zurück zum Zitat Pearce SH, Razvi S, Yadegarfar ME, et al. Serum thyroid function, mortality and disability in advanced old age: the newcastle 85+ study. J Clin Endocrinol Metab. 2016;101(11):4385–94.PubMed Pearce SH, Razvi S, Yadegarfar ME, et al. Serum thyroid function, mortality and disability in advanced old age: the newcastle 85+ study. J Clin Endocrinol Metab. 2016;101(11):4385–94.PubMed
19.
Zurück zum Zitat Vadiveloo T, Donnan PT, Murphy MJ, et al. Age- and gender-specific TSH reference intervals in people with no obvious thyroid disease in Tayside, Scotland: the thyroid epidemiology, audit and research study (TEARS). J Clin Endocrinol Metab. 2013;98(3):1147–53. Vadiveloo T, Donnan PT, Murphy MJ, et al. Age- and gender-specific TSH reference intervals in people with no obvious thyroid disease in Tayside, Scotland: the thyroid epidemiology, audit and research study (TEARS). J Clin Endocrinol Metab. 2013;98(3):1147–53.
20.
Zurück zum Zitat Gourmelon R, Donadio-Andréi S, Chikh K, et al. Subclinical hypothyroidism: Is it really subclinical with aging? Aging Dis. 2019;10(3):520–9.PubMed Gourmelon R, Donadio-Andréi S, Chikh K, et al. Subclinical hypothyroidism: Is it really subclinical with aging? Aging Dis. 2019;10(3):520–9.PubMed
21.
Zurück zum Zitat Garber JR, Cobin RH, Gharib H, Hennessey JV, et al. Clinical practice guidelines for hypothyroidism in adults: cosponsored by the American Association of Clinical Endocrinologists and the American Thyroid Association. Endocr Pract. 2012;18(6):988–1028. Garber JR, Cobin RH, Gharib H, Hennessey JV, et al. Clinical practice guidelines for hypothyroidism in adults: cosponsored by the American Association of Clinical Endocrinologists and the American Thyroid Association. Endocr Pract. 2012;18(6):988–1028.
22.
Zurück zum Zitat Wiersinga WM, Duntas L, Fadeyev V, et al. 2012 ETA guidelines: the use of L‑T4 + L‑T3 in the treatment of hypothyroidism. Eur Thyroid J. 2012;1(2):55–71.PubMed Wiersinga WM, Duntas L, Fadeyev V, et al. 2012 ETA guidelines: the use of L‑T4 + L‑T3 in the treatment of hypothyroidism. Eur Thyroid J. 2012;1(2):55–71.PubMed
23.
Zurück zum Zitat Gupta G, Sharma P, Kumar P, Itagappa M. Study on subclinical hypothyroidism and its association with various inflammatory markers. J Clin Diagn Res. 2015;9(11):BC4–BC6.PubMed Gupta G, Sharma P, Kumar P, Itagappa M. Study on subclinical hypothyroidism and its association with various inflammatory markers. J Clin Diagn Res. 2015;9(11):BC4–BC6.PubMed
24.
Zurück zum Zitat Yang C, Lu M, Chen W, et al. Thyrotropin aggravates atherosclerosis by promoting macrophage inflammation in plaques. J Exp Med. 2019;216(5):1182.PubMed Yang C, Lu M, Chen W, et al. Thyrotropin aggravates atherosclerosis by promoting macrophage inflammation in plaques. J Exp Med. 2019;216(5):1182.PubMed
25.
Zurück zum Zitat Bano A, Chaker L, de Maat MPM, et al. Thyroid function and cardiovascular disease: the mediating role of coagulation factirs. J Clin Endocrinol Metab. 2019;104:3203–12. Bano A, Chaker L, de Maat MPM, et al. Thyroid function and cardiovascular disease: the mediating role of coagulation factirs. J Clin Endocrinol Metab. 2019;104:3203–12.
26.
Zurück zum Zitat Cai Y, Manio MM, Leung GP, et al. Thyroid hormone affects both endothelial and vascular smooth muscle cells in rat arteries. Eur J Pharmacol. 2015;747:18–28. Cai Y, Manio MM, Leung GP, et al. Thyroid hormone affects both endothelial and vascular smooth muscle cells in rat arteries. Eur J Pharmacol. 2015;747:18–28.
27.
Zurück zum Zitat Lekakis J, Papamichael C, Alevizaki M, et al. Flow-mediated, endothelium-dependent vasodilation is impaired in subjects with hypothyroidism, boderline hypothyroidism, and high-normal serum (TSH) values. Thyroid. 1997;7:411–4. Lekakis J, Papamichael C, Alevizaki M, et al. Flow-mediated, endothelium-dependent vasodilation is impaired in subjects with hypothyroidism, boderline hypothyroidism, and high-normal serum (TSH) values. Thyroid. 1997;7:411–4.
28.
Zurück zum Zitat Beukhof CM, Massolt ET, Visser TJ, et al. Effects of thyrotropin on peripheral thyroid hormone metabolism and serum lipids. Thyroid. 2018;28(2):168–74. Beukhof CM, Massolt ET, Visser TJ, et al. Effects of thyrotropin on peripheral thyroid hormone metabolism and serum lipids. Thyroid. 2018;28(2):168–74.
29.
Zurück zum Zitat Razvi S, Ingoe L, Keeka G, et al. The beneficial effect of L‑thyroxine on cardiovascular risk factors, endothelial function, and quality of life in subclinical hypothyroidism: randomized, crossover trial. J Clin Endocrinol Metab. 2007;92(5):1715–23. Razvi S, Ingoe L, Keeka G, et al. The beneficial effect of L‑thyroxine on cardiovascular risk factors, endothelial function, and quality of life in subclinical hypothyroidism: randomized, crossover trial. J Clin Endocrinol Metab. 2007;92(5):1715–23.
30.
Zurück zum Zitat Andersen MN, Olsen AM, Madsen JC, et al. Levothyroxine substitution in patients with subclinical hypothyroidism and the risk of myocardial infarction and mortality. PLoS One. 2015;10(6):e129793.PubMed Andersen MN, Olsen AM, Madsen JC, et al. Levothyroxine substitution in patients with subclinical hypothyroidism and the risk of myocardial infarction and mortality. PLoS One. 2015;10(6):e129793.PubMed
31.
Zurück zum Zitat Hak AE, Pols HA, Visser TJ, et al. Subclinical hypothyroidism is an independent risk factor for atherosclerosis and myocardial infarction in elderly women: the Rotterdam study. Ann Intern Med. 2000;132(4):270–8. Hak AE, Pols HA, Visser TJ, et al. Subclinical hypothyroidism is an independent risk factor for atherosclerosis and myocardial infarction in elderly women: the Rotterdam study. Ann Intern Med. 2000;132(4):270–8.
32.
Zurück zum Zitat Thayakaran R, Adderley NJ, Sainsbury C, et al. Thyroid replacement therapy, thyroid stimulating hormone concentrations, and long term health outcomes in patients with hypothyroidism: longitudinal study. BMJ. 2019;366:I4892. Thayakaran R, Adderley NJ, Sainsbury C, et al. Thyroid replacement therapy, thyroid stimulating hormone concentrations, and long term health outcomes in patients with hypothyroidism: longitudinal study. BMJ. 2019;366:I4892.
33.
Zurück zum Zitat He W, Li S, Zhang JA, et al. Effect of levothyroxine on blood pressure in patients with subclinical hypothyroidism: a systematic review and meta-analysis. Front Endocrinol. 2018;9:454. He W, Li S, Zhang JA, et al. Effect of levothyroxine on blood pressure in patients with subclinical hypothyroidism: a systematic review and meta-analysis. Front Endocrinol. 2018;9:454.
34.
Zurück zum Zitat Meier C, Staub JJ, Roth CB, et al. TSH-controlled L‑thyroxine therapy reduces cholesterol levels and clinical symptoms in subclinical hypothyroidism: a double blind, placebo-controlled trial (Basel Thyroid Study). J Clin Endocrinol Metab. 2001;86(10):4860–6. Meier C, Staub JJ, Roth CB, et al. TSH-controlled L‑thyroxine therapy reduces cholesterol levels and clinical symptoms in subclinical hypothyroidism: a double blind, placebo-controlled trial (Basel Thyroid Study). J Clin Endocrinol Metab. 2001;86(10):4860–6.
35.
Zurück zum Zitat Calsolaro V, Niccolai F, Pasqualetti N. Overt and subclinical hypothyroidism in the elderly: when to treat? Front Endocrinol (Lausanne). 2019;10:177. Calsolaro V, Niccolai F, Pasqualetti N. Overt and subclinical hypothyroidism in the elderly: when to treat? Front Endocrinol (Lausanne). 2019;10:177.
36.
Zurück zum Zitat Gussekloo J, van Exel E, de Craen AJ, et al. Thyroid status, disability and cognitive function, and survival in old age. JAMA. 2004;292(21):2591–9. Gussekloo J, van Exel E, de Craen AJ, et al. Thyroid status, disability and cognitive function, and survival in old age. JAMA. 2004;292(21):2591–9.
37.
Zurück zum Zitat Pasqualetti G, Pagano G, Rengo G. Subclinical hypothyroidism and cognitive impairment: systematic review and meta-analysis. J Clin Endocrinol Metab. 2015;100(11):4240–8. Pasqualetti G, Pagano G, Rengo G. Subclinical hypothyroidism and cognitive impairment: systematic review and meta-analysis. J Clin Endocrinol Metab. 2015;100(11):4240–8.
38.
Zurück zum Zitat Virgini VS, Rodondi N, Cawthon PM. Subclinical thyroid dysfunction and frailty among older men. J Clin Endocrinol Metab. 2015;100(12):4524–32.PubMed Virgini VS, Rodondi N, Cawthon PM. Subclinical thyroid dysfunction and frailty among older men. J Clin Endocrinol Metab. 2015;100(12):4524–32.PubMed
39.
Zurück zum Zitat Stott DJ, Rodondi N, Kearney PM, et al. Thyroid hormone therapy for older adults with subclinical hypothyroidism. N Engl J Med. 2017;376:2534–44. Stott DJ, Rodondi N, Kearney PM, et al. Thyroid hormone therapy for older adults with subclinical hypothyroidism. N Engl J Med. 2017;376:2534–44.
40.
Zurück zum Zitat Roberts L, McCahon D, Johnson O. Stability of thyroid function in older adults: the Birmingham Elderly Thyroid study. Br J Gen Pract. 2018;68(675):e718–e26.PubMed Roberts L, McCahon D, Johnson O. Stability of thyroid function in older adults: the Birmingham Elderly Thyroid study. Br J Gen Pract. 2018;68(675):e718–e26.PubMed
41.
Zurück zum Zitat Pearce SHS, Brabant G, Duntas LH, et al. ETA guideline: management of subclinical hypothyroidism. Eur Thyroid J. 2013;2:215–28.PubMed Pearce SHS, Brabant G, Duntas LH, et al. ETA guideline: management of subclinical hypothyroidism. Eur Thyroid J. 2013;2:215–28.PubMed
42.
Zurück zum Zitat Bensenor IM, Olmos RD, Lotufo PA. Hypothyroidism in the elderly: diagnosis and management. Clin Interv Aging. 2012;7:97–111.PubMed Bensenor IM, Olmos RD, Lotufo PA. Hypothyroidism in the elderly: diagnosis and management. Clin Interv Aging. 2012;7:97–111.PubMed
43.
Zurück zum Zitat Vanderpump MP, Tunbridge WM, French JM. The incidence of thyroid disorders in the community: a twenty-year follow-up of the Whickham Survey. Clin Endocrinol (Oxf). 1995;43(1):55–68. Vanderpump MP, Tunbridge WM, French JM. The incidence of thyroid disorders in the community: a twenty-year follow-up of the Whickham Survey. Clin Endocrinol (Oxf). 1995;43(1):55–68.
44.
Zurück zum Zitat Knudsen N, Bülow I, Jørgensen T, et al. Comparative study of thyroid function and types of thyroid dysfunction in two areas in Denmark with slightly different iodine status. Eur J Endocrinol. 2000;143:485–91. Knudsen N, Bülow I, Jørgensen T, et al. Comparative study of thyroid function and types of thyroid dysfunction in two areas in Denmark with slightly different iodine status. Eur J Endocrinol. 2000;143:485–91.
45.
Zurück zum Zitat Laurberg P, Pedersen KM, Hreidarsson A, et al. Iodine intake and the pattern of thyroid disorders: a comparative epidemiological study of thyroid abnormalities in the elderly in Iceland and in Jutland, Denmark. J Clin Endocrinol Metab. 1998;83(3):765–9. Laurberg P, Pedersen KM, Hreidarsson A, et al. Iodine intake and the pattern of thyroid disorders: a comparative epidemiological study of thyroid abnormalities in the elderly in Iceland and in Jutland, Denmark. J Clin Endocrinol Metab. 1998;83(3):765–9.
46.
Zurück zum Zitat Ross DS, Burch HB, Cooper DS. 2016 American Thyroid Association guidelines for diagnosis and management of hyperthyroidism and other causes of thyrotoxicosis. Thyroid. 2016;26(10):1343–421. Ross DS, Burch HB, Cooper DS. 2016 American Thyroid Association guidelines for diagnosis and management of hyperthyroidism and other causes of thyrotoxicosis. Thyroid. 2016;26(10):1343–421.
47.
Zurück zum Zitat Trivalle C, Doucet J, Chassagne P. Differences in the signs and symptoms of hyperthyroidism in older and younger patients. J Am Geriatr Soc. 1996;44(1):50–3. Trivalle C, Doucet J, Chassagne P. Differences in the signs and symptoms of hyperthyroidism in older and younger patients. J Am Geriatr Soc. 1996;44(1):50–3.
48.
Zurück zum Zitat Sawin CT, Geller A, Wolf PA, et al. Low serum thyrotropin concentrations as a risk factor for atrial fibrillation in older persons. N Engl J Med. 1994;331:1249–52. Sawin CT, Geller A, Wolf PA, et al. Low serum thyrotropin concentrations as a risk factor for atrial fibrillation in older persons. N Engl J Med. 1994;331:1249–52.
49.
Zurück zum Zitat Selmer C, Olesen JB, Hansen ML, Lindhardsen J, Olsen AM, Madsen JC, et al. The spectrum of thyroid disease and risk of new onset atrial fibrillation: a large population cohort study. BMJ. 2012;345:e7895.PubMed Selmer C, Olesen JB, Hansen ML, Lindhardsen J, Olsen AM, Madsen JC, et al. The spectrum of thyroid disease and risk of new onset atrial fibrillation: a large population cohort study. BMJ. 2012;345:e7895.PubMed
50.
Zurück zum Zitat Baumgartner C, da Costa BR, Collet TH. Thyroid function within the normal range, subclinical hypothyroidism, and the risk of atrial fibrillation. Circulation. 2017;136:2100–16.PubMed Baumgartner C, da Costa BR, Collet TH. Thyroid function within the normal range, subclinical hypothyroidism, and the risk of atrial fibrillation. Circulation. 2017;136:2100–16.PubMed
51.
Zurück zum Zitat Heidari R, Niknahad H, Jamshidzadeh A, et al. Factors affecting drug-induced liver injury: antithyroid drugs as instances. Clin Mol Hepatol. 2014;20(3):237–48.PubMed Heidari R, Niknahad H, Jamshidzadeh A, et al. Factors affecting drug-induced liver injury: antithyroid drugs as instances. Clin Mol Hepatol. 2014;20(3):237–48.PubMed
52.
Zurück zum Zitat Cooper DS, Goldminz D, Levin AA. Agranulocytosis associated with antithyroid drugs. Effects of patient age and drug dose. Ann Intern Med. 1983;98(1):26–9. Cooper DS, Goldminz D, Levin AA. Agranulocytosis associated with antithyroid drugs. Effects of patient age and drug dose. Ann Intern Med. 1983;98(1):26–9.
53.
Zurück zum Zitat Azizi F, Takyar M, Madreseh E, et al. Treatment of toxic multinodular goiter: comparison of radioiodine and long-term methimazole treatment. Thyroid. 2019;29(5):625–530. Azizi F, Takyar M, Madreseh E, et al. Treatment of toxic multinodular goiter: comparison of radioiodine and long-term methimazole treatment. Thyroid. 2019;29(5):625–530.
54.
Zurück zum Zitat Bonnema SJ, Hegedus L. Radioiodine therapy in benign thyroid diseases: effects, side effects, and factors affecting therapeutic outcome. Endocr Rev. 2012;33:920–80. Bonnema SJ, Hegedus L. Radioiodine therapy in benign thyroid diseases: effects, side effects, and factors affecting therapeutic outcome. Endocr Rev. 2012;33:920–80.
55.
Zurück zum Zitat Torring O, Tallstedt L, Wallin G, et al. Graves’ hyperthyroidism: treatment with antithyroid drugs, surgery, or radioiodine—a prospective, randomized study. Thyroid Study Group. J Clin Endocrinol Metab. 1996;81:2986–93. Torring O, Tallstedt L, Wallin G, et al. Graves’ hyperthyroidism: treatment with antithyroid drugs, surgery, or radioiodine—a prospective, randomized study. Thyroid Study Group. J Clin Endocrinol Metab. 1996;81:2986–93.
56.
Zurück zum Zitat Nygaard B, Hegedus L, Gervil M, et al. Influence of compensated radioiodine therapy on thyroid volume and incidence of hypothyroidism in Graves’ disease. J Intern Med. 1995;238:491–7. Nygaard B, Hegedus L, Gervil M, et al. Influence of compensated radioiodine therapy on thyroid volume and incidence of hypothyroidism in Graves’ disease. J Intern Med. 1995;238:491–7.
57.
Zurück zum Zitat Pajamäki N, Metso S, Hakala T, et al. Long-term cardiovascular morbidity and mortality in patients treated for differentiated thyroid cancer. Clin Endocrinol. 2018;88(2):303–10. Pajamäki N, Metso S, Hakala T, et al. Long-term cardiovascular morbidity and mortality in patients treated for differentiated thyroid cancer. Clin Endocrinol. 2018;88(2):303–10.
58.
Zurück zum Zitat Moon JH, Kim KM, Oh TJ, et al. The effect of TSH suppression on vertebral trabecular bone scores in patients with differentiated thyroid carcinoma. J Clin Endocrinol Metab. 2017;102(1):78–85. Moon JH, Kim KM, Oh TJ, et al. The effect of TSH suppression on vertebral trabecular bone scores in patients with differentiated thyroid carcinoma. J Clin Endocrinol Metab. 2017;102(1):78–85.
59.
Zurück zum Zitat Kachui A, Tabatabaizadeh SM, Iraj B. Evaluation of bone density, serum total and ionized calcium, alkaline phosphatase and 25-hydroxy vitamin D in papillary thyroid carcinoma, and their relationship with TSH suppression by levothyroxine. Adv Biomed Res. 2017;6:94.PubMed Kachui A, Tabatabaizadeh SM, Iraj B. Evaluation of bone density, serum total and ionized calcium, alkaline phosphatase and 25-hydroxy vitamin D in papillary thyroid carcinoma, and their relationship with TSH suppression by levothyroxine. Adv Biomed Res. 2017;6:94.PubMed
60.
Zurück zum Zitat Blum MR, Bauer DC, Collet TH, et al. Subclinical thyroid dysfunction and fracture risk: a meta-analysis. JAMA. 2015;313(20):2055–65.PubMed Blum MR, Bauer DC, Collet TH, et al. Subclinical thyroid dysfunction and fracture risk: a meta-analysis. JAMA. 2015;313(20):2055–65.PubMed
61.
Zurück zum Zitat Park J, Blackburn BE, Ganz PA. Risk factors for cardiovascular disease among thyroid cancer survivors: findings from the utah cancer survivors study. J Clin Endocrinol Metab. 2018;103:2468–77.PubMed Park J, Blackburn BE, Ganz PA. Risk factors for cardiovascular disease among thyroid cancer survivors: findings from the utah cancer survivors study. J Clin Endocrinol Metab. 2018;103:2468–77.PubMed
62.
Zurück zum Zitat Collet TH, Gussekloo J, Bauer DC, et al. Subclinical hyperthyroidism and the risk of coronary heart disease and mortality. Arch Intern Med. 2012;172(10):799–809. Collet TH, Gussekloo J, Bauer DC, et al. Subclinical hyperthyroidism and the risk of coronary heart disease and mortality. Arch Intern Med. 2012;172(10):799–809.
63.
Zurück zum Zitat Parle JV, Maisonneuve P, Sheppard MC, et al. Prediction of all-cause and cardiovascular mortality in elderly people from one low serum thyrotropin result: a 10-year cohort study. Lancet. 2001;358(9285):861–5. Parle JV, Maisonneuve P, Sheppard MC, et al. Prediction of all-cause and cardiovascular mortality in elderly people from one low serum thyrotropin result: a 10-year cohort study. Lancet. 2001;358(9285):861–5.
64.
Zurück zum Zitat Bano A, Dhana K, Chaker L, et al. Association of thyroid function with life expectancy with and without cardiovascular disease. JAMA Intern Med. 2017;177(11):1650–7.PubMed Bano A, Dhana K, Chaker L, et al. Association of thyroid function with life expectancy with and without cardiovascular disease. JAMA Intern Med. 2017;177(11):1650–7.PubMed
65.
Zurück zum Zitat Ceresini G, Ceda GP, Lauretani F, et al. Thyroid status and 6‑year mortality in elderly people living in a mildly iodine-deficient area: the aging in the Chianti Area study. J Am Geriatr Soc. 2013;61(6):868–74.PubMed Ceresini G, Ceda GP, Lauretani F, et al. Thyroid status and 6‑year mortality in elderly people living in a mildly iodine-deficient area: the aging in the Chianti Area study. J Am Geriatr Soc. 2013;61(6):868–74.PubMed
66.
Zurück zum Zitat Yeap BB, Alfonso H, Hankey GJ, et al. Higher free thyroxine levels are associated with all-cause mortality in euthyroid older men: the Health in Men study. Eur J Endocrinol. 2013;169(4):401–8. Yeap BB, Alfonso H, Hankey GJ, et al. Higher free thyroxine levels are associated with all-cause mortality in euthyroid older men: the Health in Men study. Eur J Endocrinol. 2013;169(4):401–8.
67.
Zurück zum Zitat Bano A, Chaker L, Schoufour J, et al. High circulating free thyroxine levels may increase the risk of frailty: the Rotterdam study. J Clin Endocrinol Metab. 2018;103(1):328–35. Bano A, Chaker L, Schoufour J, et al. High circulating free thyroxine levels may increase the risk of frailty: the Rotterdam study. J Clin Endocrinol Metab. 2018;103(1):328–35.
68.
Zurück zum Zitat Khan SR, Chaker L, Ruiter R, et al. Thyroid function and cancer risk: the Rotterdam study. J Clin Endocrinol Metab. 2016;101(12):5030–6. Khan SR, Chaker L, Ruiter R, et al. Thyroid function and cancer risk: the Rotterdam study. J Clin Endocrinol Metab. 2016;101(12):5030–6.
69.
Zurück zum Zitat Aubert CE, Bauer DC, da Costa BR. The association between subclinical thyroid dysfunction and dementia: the Health, Aging and Body Composition (Health ABC) study. Clin Endocrinol (Oxf). 2017;87(5):617–26. Aubert CE, Bauer DC, da Costa BR. The association between subclinical thyroid dysfunction and dementia: the Health, Aging and Body Composition (Health ABC) study. Clin Endocrinol (Oxf). 2017;87(5):617–26.
70.
Zurück zum Zitat Ceresini G, Lauretani F, Maggio M, et al. Thyroid function abnormalities and cognitive impairment in elderly people: results of the Invecchiare in Chianti study. J Am Geriatr Soc. 2009;57(1):89–93. Ceresini G, Lauretani F, Maggio M, et al. Thyroid function abnormalities and cognitive impairment in elderly people: results of the Invecchiare in Chianti study. J Am Geriatr Soc. 2009;57(1):89–93.
71.
Zurück zum Zitat Das G, Ojewuyi TA, Baglioni P, et al. Serum thyrotropin at baseline predicts the natural course of subclinical hyperthyroidism. Clin Endocrinol. 2012;77:146–51. Das G, Ojewuyi TA, Baglioni P, et al. Serum thyrotropin at baseline predicts the natural course of subclinical hyperthyroidism. Clin Endocrinol. 2012;77:146–51.
72.
Zurück zum Zitat Biondi B, Bartalena L, Cooper DS, et al. The 2015 European Thyroid Association guidelines on diagnosis and treatment of endogenous subclinical hyperthyroidism. Eur Thyroid J. 2015;4:149–63.PubMed Biondi B, Bartalena L, Cooper DS, et al. The 2015 European Thyroid Association guidelines on diagnosis and treatment of endogenous subclinical hyperthyroidism. Eur Thyroid J. 2015;4:149–63.PubMed
73.
Zurück zum Zitat Martino E, Bartalena L, Bogazzi F, et al. The effects of amiodarone on the thyroid. Endocr Rev. 2001;22(2):240–54. Martino E, Bartalena L, Bogazzi F, et al. The effects of amiodarone on the thyroid. Endocr Rev. 2001;22(2):240–54.
74.
Zurück zum Zitat Bartalena L, Bogazzi F, Chiovato L, et al. European Thyroid Association (ETA) guidelines for the management of amiodarone-associated thyroid dysfunction. Eur Thyroid J. 2018;7:55–66.PubMed Bartalena L, Bogazzi F, Chiovato L, et al. European Thyroid Association (ETA) guidelines for the management of amiodarone-associated thyroid dysfunction. Eur Thyroid J. 2018;7:55–66.PubMed
75.
Zurück zum Zitat Lind P, Klima G, Wakonig P, et al. Urinary excretion of iodide and incidence of goiter in Styria—studies 20 years after the introduction of compulsory iodinated salt prophylaxis. Acta Med Austriaca. 1985;12:45–50. Lind P, Klima G, Wakonig P, et al. Urinary excretion of iodide and incidence of goiter in Styria—studies 20 years after the introduction of compulsory iodinated salt prophylaxis. Acta Med Austriaca. 1985;12:45–50.
76.
Zurück zum Zitat Heinisch M, Kumnig G, Asböck D, et al. Goiter prevalence and urinary iodide excretion in a formerly iodine-deficient region after introduction of statutory iodization of common salt. Thyroid. 2002;12:809–14.PubMed Heinisch M, Kumnig G, Asböck D, et al. Goiter prevalence and urinary iodide excretion in a formerly iodine-deficient region after introduction of statutory iodization of common salt. Thyroid. 2002;12:809–14.PubMed
77.
Zurück zum Zitat Lind P, Kumnig G, Heinisch M, et al. Iodine supplementation in Austria: methods and results. Thyroid. 2002;12(10):903–7. Lind P, Kumnig G, Heinisch M, et al. Iodine supplementation in Austria: methods and results. Thyroid. 2002;12(10):903–7.
78.
Zurück zum Zitat Gallowitsch HJ, Mikosch P, Kresnik E, et al. Thyroid volume and iodine supply of 6 to 17 year old students. Results 3 years after the introduction of increased iodized salt. Nuklearmedizin. 1994;33:235–8.PubMed Gallowitsch HJ, Mikosch P, Kresnik E, et al. Thyroid volume and iodine supply of 6 to 17 year old students. Results 3 years after the introduction of increased iodized salt. Nuklearmedizin. 1994;33:235–8.PubMed
81.
Zurück zum Zitat Lindorfer H, Krebs M, Kautzky-Willer A, et al. Iodine deficiency in pregnant women in Austria. Eur J Clin Nutr. 2015;69:349–54. Lindorfer H, Krebs M, Kautzky-Willer A, et al. Iodine deficiency in pregnant women in Austria. Eur J Clin Nutr. 2015;69:349–54.
82.
Zurück zum Zitat Hannan SA. The magnificent seven: a history of modern thyroid surgery. Int J Surg. 2006;4:187–91. Hannan SA. The magnificent seven: a history of modern thyroid surgery. Int J Surg. 2006;4:187–91.
83.
Zurück zum Zitat Verloop H, Louwerens M, Schoones JW. Risk of hypothyroidism following hemithyroidectomy: systematic review and meta-analysis of prognostic studies. J Clin Endocrinol Metab. 2012;97(7):2243–5558. Verloop H, Louwerens M, Schoones JW. Risk of hypothyroidism following hemithyroidectomy: systematic review and meta-analysis of prognostic studies. J Clin Endocrinol Metab. 2012;97(7):2243–5558.
84.
Zurück zum Zitat Kurtaran A, Schmoll-Hauer B, Tugendsam C. Current controversies in risk-adapted therapy in differentiated thyroid cancer: Is less (therapy) really more? Wien Med Wochenschr. 2020;170(1–2):15–25. Kurtaran A, Schmoll-Hauer B, Tugendsam C. Current controversies in risk-adapted therapy in differentiated thyroid cancer: Is less (therapy) really more? Wien Med Wochenschr. 2020;170(1–2):15–25.
85.
Zurück zum Zitat Haymart MR, Esfandiari NH, Stang MT, et al. Controversies in the management of low-risk differentiated thyroid cancer. Endocr Rev. 2017;38(4):351–78.PubMed Haymart MR, Esfandiari NH, Stang MT, et al. Controversies in the management of low-risk differentiated thyroid cancer. Endocr Rev. 2017;38(4):351–78.PubMed
86.
Zurück zum Zitat Haugen BR, Alexander EK, Bible KC, et al. American Thyroid Association guidelines for adult patients with thyroid nodules and differentiated thyroid cancer. Thyroid. 2016;26:1–133.PubMed Haugen BR, Alexander EK, Bible KC, et al. American Thyroid Association guidelines for adult patients with thyroid nodules and differentiated thyroid cancer. Thyroid. 2016;26:1–133.PubMed
87.
Zurück zum Zitat Silverman JF, West RL, Larkin EW, et al. The role of fine-needle aspiration biopsy in the rapid diagnosis and management of thyroid neoplasm. Cancer. 1986;57(6):1164–70. Silverman JF, West RL, Larkin EW, et al. The role of fine-needle aspiration biopsy in the rapid diagnosis and management of thyroid neoplasm. Cancer. 1986;57(6):1164–70.
88.
Zurück zum Zitat Kwak JY, Han KH, Yoon JH, et al. Thyroid imaging reporting and data system for US features of nodules: a step in establishing better stratification of cancer risk. Radiology. 2011;260:892–9. Kwak JY, Han KH, Yoon JH, et al. Thyroid imaging reporting and data system for US features of nodules: a step in establishing better stratification of cancer risk. Radiology. 2011;260:892–9.
89.
Zurück zum Zitat Tugendsam C, Petz V, Buchinger W, et al. Ultrasound criteria for risk stratification of thyroid nodules in the previously iodine deficient area of Austria—a single centre, retrospective analysis. Thyroid Res. 2018;9(11):3. Tugendsam C, Petz V, Buchinger W, et al. Ultrasound criteria for risk stratification of thyroid nodules in the previously iodine deficient area of Austria—a single centre, retrospective analysis. Thyroid Res. 2018;9(11):3.
90.
Zurück zum Zitat Belfiore A, La Rosa GL, La Porta GA, et al. Cancer risk in patients with cold thyroid nodules: relevance of iodine intake, sex, age, and multinodularity. Am J Med. 1992;93(4):363–9. Belfiore A, La Rosa GL, La Porta GA, et al. Cancer risk in patients with cold thyroid nodules: relevance of iodine intake, sex, age, and multinodularity. Am J Med. 1992;93(4):363–9.
91.
Zurück zum Zitat Crockett JC. The thyroid nodule: fine-needle aspiration biopsy technique. Thrombosis J. 2017;15:14. Crockett JC. The thyroid nodule: fine-needle aspiration biopsy technique. Thrombosis J. 2017;15:14.
92.
Zurück zum Zitat Knobel M. Which is the ideal treatment for benign diffuse and multinodular non-toxic goiters? Front Endocrinol (Lausanne). 2016;7:48. Knobel M. Which is the ideal treatment for benign diffuse and multinodular non-toxic goiters? Front Endocrinol (Lausanne). 2016;7:48.
93.
Zurück zum Zitat Bartsch DK, Luster M, Buhr HJ. Indications for the surgical management of benign goiter in adults. Dtsch Arztebl Int. 2018;115:1–7. Bartsch DK, Luster M, Buhr HJ. Indications for the surgical management of benign goiter in adults. Dtsch Arztebl Int. 2018;115:1–7.
94.
Zurück zum Zitat Mostbeck A, Galvan G, Bauer P, et al. The incidence of hyperthyroidism in Austria from 1987 to 1995 before and after an increase in salt iodization in 1990. Eur J Nucl Med. 1998;25(4):367–74. Mostbeck A, Galvan G, Bauer P, et al. The incidence of hyperthyroidism in Austria from 1987 to 1995 before and after an increase in salt iodization in 1990. Eur J Nucl Med. 1998;25(4):367–74.
95.
Zurück zum Zitat Testini M, Gurrado A, Avenia N, et al. Does mediastinal extension of the goiter increase morbidity of total thyroidectomy? A multicenter study of 19,662 patients. Ann Surg Oncol. 2011;18(8):2251–9. Testini M, Gurrado A, Avenia N, et al. Does mediastinal extension of the goiter increase morbidity of total thyroidectomy? A multicenter study of 19,662 patients. Ann Surg Oncol. 2011;18(8):2251–9.
96.
Zurück zum Zitat Ito Y, Miyauchi A, Kihara M, et al. Patient age is significantly related to the progression of papillary microcarcinoma of the thyroid under observation. Thyroid. 2014;24(1):27–34.PubMed Ito Y, Miyauchi A, Kihara M, et al. Patient age is significantly related to the progression of papillary microcarcinoma of the thyroid under observation. Thyroid. 2014;24(1):27–34.PubMed
97.
Zurück zum Zitat Joseph KR, Edirimanne S, Eslick GD. Thyroidectomy for thyroid cancer in the elderly: a meta-analysis. Eur J Surg Oncol. 2019;45(3):310–7. Joseph KR, Edirimanne S, Eslick GD. Thyroidectomy for thyroid cancer in the elderly: a meta-analysis. Eur J Surg Oncol. 2019;45(3):310–7.
98.
Zurück zum Zitat Duskin-Bitan H, Leibner A, Amitai O. Bone-marrow suppression in elderly patients following empiric radioiodine therapy: real-life data. Thyroid. 2019;29(5):683–91. Duskin-Bitan H, Leibner A, Amitai O. Bone-marrow suppression in elderly patients following empiric radioiodine therapy: real-life data. Thyroid. 2019;29(5):683–91.
99.
Zurück zum Zitat Chereau N, Trésallet C, Noullet S, et al. Prognosis of papillary thyroid carcinoma in elderly patients after thyroid resection: a retrospective cohort analysis. Medicine. 2016;95(47):e5450.PubMed Chereau N, Trésallet C, Noullet S, et al. Prognosis of papillary thyroid carcinoma in elderly patients after thyroid resection: a retrospective cohort analysis. Medicine. 2016;95(47):e5450.PubMed
100.
Zurück zum Zitat Biondi B, Cooper DS. Benefits of thyrotropin suppression versus the risks of adverse effects in differentiated thyroid cancer. Thyroid. 2010;20(2):135–46. Biondi B, Cooper DS. Benefits of thyrotropin suppression versus the risks of adverse effects in differentiated thyroid cancer. Thyroid. 2010;20(2):135–46.
101.
Zurück zum Zitat Molinaro E, Romei C, Biagini A. Anaplastic thyroid carcinoma: from clinicopathology to genetics and advanced therapies. Nat Rev Endocrinol. 2017;13:644–60. Molinaro E, Romei C, Biagini A. Anaplastic thyroid carcinoma: from clinicopathology to genetics and advanced therapies. Nat Rev Endocrinol. 2017;13:644–60.
103.
Zurück zum Zitat Bakiri F, Djemli FK, Mokrane LA, et al. The relative roles of endemic goiter and socioeconomic development status in the prognosis of thyroid carcinoma. Cancer. 1998;82(6):1146–53. Bakiri F, Djemli FK, Mokrane LA, et al. The relative roles of endemic goiter and socioeconomic development status in the prognosis of thyroid carcinoma. Cancer. 1998;82(6):1146–53.
Metadaten
Titel
Die Schilddrüse im Alter
Physiologie und Pathologie
verfasst von
Christina Tugendsam
Amir Kurtaran
Publikationsdatum
22.06.2020
Verlag
Springer Vienna
Erschienen in
Wiener Medizinische Wochenschrift / Ausgabe 15-16/2020
Print ISSN: 0043-5341
Elektronische ISSN: 1563-258X
DOI
https://doi.org/10.1007/s10354-020-00761-2

Weitere Artikel der Ausgabe 15-16/2020

Wiener Medizinische Wochenschrift 15-16/2020 Zur Ausgabe